medtronic inc the food and drug administration completed an investigation of safety issues raised by a former medtronic inc employee about a wireless device used to treat heart failure the agency said nothing was found that would have influenced its decision to approve the device the complaint by the former employee centered on the wireless monitoring capabilities of the device called concerto which was approved by the fda in may fda spokeswoman heidi rebello said the investigation included a scientific review of the former employees allegations an inspection of the companys manufacturing facility and a review of various available data medtronic said it has had no reports of patient safety issues related to the wireless features of the device medtronic spokesman rob clark said the company also thoroughly investigated the concerns and either addressed them or found them without merit 
